Insiders · Profile

Kelly John Alexander

Chief Financial Officer at PRECISION BIOSCIENCES. Filing since 17 Mar 2022. CIK 0001590030

Company
Date
Role
Action
Shares
Amount
Of holding
18 Feb 2026
Chief Financial Officer
Sold on a plan
8,149
$31.29K
6.1%
21 Jan 2026
Chief Financial Officer
Sold on a plan
15,213
$61.31K
12.5%
3 Nov 2025
Chief Financial Officer
Sold on a plan
1,303
$8.46K
1.7%
3 Jul 2025
Chief Financial Officer
Sold on a plan
14,827
$63.16K
16.8%
27 Dec 2024
Chief Financial Officer
Bought
2,113
$10.04K
5.5%
21 Nov 2024
Chief Financial Officer
Bought
3,000
$20.28K
8.6%
17 Mar 2023
Chief Financial Officer
Bought
20,000
$17.20K
8.9%
23 Sep 2022
Chief Financial Officer
Bought
8,200
$10.09K
5.3%
22 Sep 2022
Chief Financial Officer
Bought
37,037
$49.63K
31.5%
22 Jun 2022
Chief Financial Officer
Bought
33,784
$50.68K
40.3%
17 Mar 2022
Chief Financial Officer
Bought
16,677
$51.37K
85.5%
11 decisions on file.